GENGOS ANDREW (Chief Financial Officer) received a stock award from TERNS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/16/2026ACC: 0001563623-26-000002
Officer· Chief Financial Officer
Since Feb 2025
+206.25K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
206.25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+68.75K
Price / share
—
Trade value
—
% of position
208.1%
1/14/2026
33.04K→101.79K
Total
Net shares
+68.75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/14/2026 | A · Award | +68.75K | — | — | 208.1% | 33.04K | 101.79K |
| Total | +68.75K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
137.50K shares
Shares
+137.50K
Strike price
37.18
Held after
137.50K
Exercisable
—
1/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock137.50K shares | 1/14/2026 | A · Award | +137.50K | 37.18 | — | 137.50K |